Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Arcadia Biosciences (RKDA) reported a Q3 loss of $0.87 per share, which was larger than the Zacks Consensus Estimate of a $0.77 loss. However, the company topped revenue estimates.
November 13, 2024 | 1:30 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Arcadia Biosciences reported a Q3 loss of $0.87 per share, missing the consensus estimate of $0.77. Despite the larger loss, the company exceeded revenue expectations.
The larger-than-expected loss per share is a negative indicator, but the fact that revenue exceeded expectations could offset some of the negative sentiment. This mixed result may lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100